Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 54

Bank hybrid market undergoing significant change

An important change has hit the ASX listed bank hybrid market recently that we think may lead to a contraction of margins on listed hybrids for the remainder of the year.

Since the drafting of Basel III regulations in 2010, bank hybrid structures had been shunned by institutional investors who refused en masse to accept the so-called ‘non-viability’ clauses embedded in Basel III complying hybrid structures. The non-viability clause allows the regulator to convert the hybrid to equity to improve a bank’s solvency under crisis conditions. Such a clause has obvious risks, which retail investors either overlooked or ignored, while institutions thought it gave the issues too much ‘equity’ characteristic without sufficient return.

A flagship Tier 2 capital issue by Bendigo & Adelaide Bank in January 2014 saw institutional investors participate for the first time under the new bank capital regime. Westpac, ANZ and IAG have all issued into the wholesale over the counter (OTC) market to institutional investors since.

The institutional dislike of the 'non viability' clause relates to the absolute ability of APRA to exercise its option to convert capital instruments. To date, APRA has given no  guidance as to when it will exercise this ability and has told banks that “we will know a non viability scenario when we see it”. It’s not totally clear what the reasons are for the recent change of mind by institutional investors, and it may include the still attractive margins or fewer fears about the global banking system. It hasn’t been guidance from APRA about when it will use the 'non viability' clause.

We believe that the change in institutional investor sentiment has the potential to squeeze supply for the retail ASX listed market for the rest of 2014.

Maintenance of 3% margins since the implementation of Basel III

A few months ago, we thought the listed hybrid market would produce a total return this year close to 6% (including franking). However, due to the changed sentiment of institutional investors in the wholesale OTC market, there now appears potential for spread contraction and capital growth in prices in the listed hybrid market. Absent another equity market crisis or major event shock, we think that listed major bank issues are unlikely to attract a margin of greater than 3% again (the margin is paid above the bank bill rates, currently below 3%, and adjusted for franking).

The chart below shows margins on US corporate BBB and BB debt and the composite margin of ASX Listed Major Bank Hybrids. The zero cash rate in the US has driven investors into higher-yielding assets since the GFC and margins on BBB and BB corporate debt are close to 1996-2006 levels, half their late 2009 levels. However, margins on the ASX Listed Major Bank Hybrids are largely unchanged, having fluctuated around 3% for the past four to five years. They were recently higher than US BB corporate debt for the first time ever.


Data: Bloomberg, ASX and Elstree

Major bank hybrid margins have been relatively flat due to a massive amount of supply as banks began to comply with the much more restrictive Basel III capital regime. In absolute terms, the market size has doubled since late 2011. Prior to the GFC, the market used to absorb about $3 billion on an annual basis. The chart below shows gross and net (after allowing for redemptions of issues) since 2007. The net issuance amount is probably the best guide to supply/demand equations.


Data: ASX and Elstree

The year 2012 was characterised by about four years of normal issuance while 2013 was about 3 years of normal issuance. Until recently, we expected that 2014 would produce about $8 billion in net issuance or $15 billion in gross issuance. The two bars for 2014 show two outcomes: the first assumes that banks refinance all their Tier 1 hybrids in the ASX market and the second adds another $6 billion of Tier 2 debt that banks need to finance. Financing $15 billion of gross issuance would mean that margins would remain high.

Institutional demand will impact directly on ASX listed issuance

The institutional acceptance of the ‘non viability’ clause in Basel III compliant transactions stems from a broad-based change in sentiment toward banks in general.

A recent issue in Europe by UBS for example was five times oversubscribed, and was issued at a record low margin. Australian banks could now issue Tier 2 capital instruments at margins well under the current trading margins of ASX listed hybrids. If the Australian bank issuers tap the international market and local institutional investors continue to follow their international contemporaries into the market then the level of net issuance in the ASX listed market could potentially fall to the level last experienced in 2006.

Unless there is a sudden reversal, institutional investors are now most likely to absorb the $6 billion of Tier 2 debt that the Australian banks need to issue this year. The chart below shows the proportion of hybrid issue ownership by the top 20 holders for each issue, grouped by years of issue. In recent years, the Top 20 (i.e institutional) investors have held as little as 20% or less of some issues, showing a high percentage of small retail investor participation, with around 40% of some issues owned by investors with less than $50,000 holdings. Investors will buy anything with the margins higher than 3% recently.


Data: Elstree and ASX.

Retail and SMSF support

In 2011, bank term deposits were readily available at rates of 6% or higher. In 2012 they were still around 5%. Driven by the volatility of equity markets, SMSF holdings of cash, including term deposits, doubled from around $70 billion in 2007 to $150 billion in 2013.

As the cash rate is now down to 2.5% and term deposits of less than 12 months are prefixed with a ‘3’ the loss of purchasing power after adjusting for inflation is causing concern among retirees. Unlike their institutional brethren, retail investors have been comfortable since the implementation of Basel III with the major bank name hybrids, and were willing to overlook the complex regulatory clauses and risks in search of total returns in excess of 6%.

Although official statistics on SMSF investments are dated and too aggregated, there are signs in the 2013 statistics of an absolute fall in cash holdings, despite total SMSF funds increasing rapidly. There is a lag between new term deposit rates falling and cash flows, but any term deposits that were written in 2012 at rates of 5% or above will now be rolling at around 3.5%. We estimate that as little as a 2% reallocation by SMSF trustees from term deposits to hybrids will account for all the expected net new issuance in the listed hybrid market this calendar year.

If institutional demand in the OTC market soaks up the bank Tier 2 issuance, there will be a shortage of ASX listed hybrid supply at the time when a decent chunk of the $150 billion in SMSF monies invested in term deposits is looking for a new home.

 

Campbell Dawson is a Director of Elstree Investment Management Limited. Information and opinions contained in this article should not relied upon as authoritative and may be subject to change without notice.

 


 

Leave a Comment:

RELATED ARTICLES

Bank limitations create opportunities for non-bank lenders

How 'ridiculous' are hybrids for retail investors?

Ian Macfarlane on emerging markets, banks and property prices

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.